Literature DB >> 7483258

Epstein-Barr virus infection of CR2-transfected epithelial cells reveals the presence of MHC class II on the virion.

P G Knox1, L S Young.   

Abstract

Epithelial cell lines transfected with the Epstein-Barr virus (EBV) receptor CR2 are susceptible to infection by EBV. Following infection with certain EBV strains we found that these cells became positive for MHC class II. The class II was confirmed as being of viral and not target cell origin by immunostaining with HLA-specific monoclonal antibodies. Electron microscopic immunogold staining confirmed the presence of MHC class II on the surface of the virion. While some MHC class I was also found on the EB virion, other cell surface molecules were absent. Dual color immunofluorescence and confocal microscopy analysis demonstrated colocalization of class II with EBV-encoded structural proteins (MA and VCA) in infected epithelial cells. However, preincubation of EBV with antibodies against either MHC class I or MHC class II failed to affect either EBV binding or EBV infection. The presence of MHC on the surface of the EB virion may be a consequence of the intracellular pathways through which productive virus exits from the cell and may influence the target cell tropism of EBV.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7483258     DOI: 10.1006/viro.1995.1555

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

Review 1.  Plunder and stowaways: incorporation of cellular proteins by enveloped viruses.

Authors:  Réjean Cantin; Sylvie Méthot; Michel J Tremblay
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

2.  The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation.

Authors:  M K Spriggs; R J Armitage; M R Comeau; L Strockbine; T Farrah; B Macduff; D Ulrich; M R Alderson; J Müllberg; J I Cohen
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes.

Authors:  Q Li; M K Spriggs; S Kovats; S M Turk; M R Comeau; B Nepom; L M Hutt-Fletcher
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

4.  Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells.

Authors:  X Wang; W J Kenyon; Q Li; J Müllberg; L M Hutt-Fletcher
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

5.  Antigen-presenting particle technology using inactivated surface-engineered viruses: induction of immune responses against infectious agents.

Authors:  Joseph D Mosca; Yung-Nien Chang; Gregory Williams
Journal:  Retrovirology       Date:  2007-05-15       Impact factor: 4.602

Review 6.  Application of proteomics technology for analyzing the interactions between host cells and intracellular infectious agents.

Authors:  Mayte Coiras; Emilio Camafeita; María Rosa López-Huertas; Enrique Calvo; Juan Antonio López; José Alcamí
Journal:  Proteomics       Date:  2008-02       Impact factor: 3.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.